The payer recorded net income of $650 million in the three months ended June 30, compared to $311 million in the same period of fiscal year 2016.
Humana’s revenue declined 3.4 percent in the second quarter of fiscal year 2017 to $13.5 billion, down from $14 billion reported in the same period a year prior. The company attributed the year-over-year decrease to lower individual commercial segment revenues.
However, the payer’s operating expenses also fell in the second quarter of fiscal year 2017 to $12.4 billion, a decrease from $13.3 billion in the second quarter of fiscal year 2016. Humana pointed to the temporary suspension of the ACA’s health insurance industry fee in 2017 as reason for the decline.
Humana ended the first six months of fiscal year 2017 with revenue of $1.8 billion compared to $565 million in the first six months of 2016.
More articles on payer issues:
15 key dates for ACA insurance marketplace ahead of open enrollment
Managed Medicaid recipients report greater satisfaction than commercial plan members
Pennsylvania eases Highmark’s reporting requirements for Allegheny Health investments
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
